Researchers have successfully demonstrated how an electronic device implanted directly into the brain can detect, stop and even prevent epileptic seizures.
These thin, organic films do minimal damage in the brain, and their electrical properties are well-suited for these types of applications.
The researchers, from the University of Cambridge, the École Nationale Supérieure des Mines and INSERM in France, implanted the device into the brains of mice, and when the first signals of a seizure were detected, delivered a native brain chemical which stopped the seizure from progressing. The results, reported in the journal Science Advances, could also be applied to other conditions including brain tumours and Parkinson’s disease.
The work represents another advance in the development of soft, flexible electronics that interface well with human tissue. “These thin, organic films do minimal damage in the brain, and their electrical properties are well-suited for these types of applications,” said Professor George Malliaras, the Prince Philip Professor of Technology in Cambridge’s Department of Engineering, who led the research.
While there are many different types of seizures, in most patients with epilepsy, neurons in the brain start firing and signal to neighbouring neurons to fire as well, in a snowball effect that can affect consciousness or motor control. Epilepsy is most commonly treated with anti-epileptic drugs, but these drugs often have serious side effects and they do not prevent seizures in three out of 10 patients.
In the current work, the researchers used a neurotransmitter which acts as the ‘brake’ at the source of the seizure, essentially signalling to the neurons to stop firing and end the seizure. The drug is delivered to the affected region of the brain by a neural probe incorporating a tiny ion pump and electrodes to monitor neural activity.
When the neural signal of a seizure is detected by the electrodes, the ion pump is activated, creating an electric field that moves the drug across an ion exchange membrane and out of the device, a process known as electrophoresis. The amount of drug can be controlled by tuning the strength of the electric field.
“In addition to being able to control exactly when and how much drug is delivered, what is special about this approach is that the drugs come out of the device without any solvent,” said lead author Dr Christopher Proctor, a postdoctoral researcher in the Department of Engineering. “This prevents damage to the surrounding tissue and allows the drugs to interact with the cells immediately outside the device.”
The researchers found that seizures could be prevented with relatively small doses of drug representing less than 1% of the total amount of drug loaded into the device. This means the device should be able to operate for extended periods without needing to be refilled. They also found evidence that the delivered drug, which was in fact a neurotransmitter that is native to the body, was taken up by natural processes in the brain within minutes which, the researchers say, should help reduce side effects from the treatment.
Although early results are promising, the potential treatment would not be available for humans for several years. The researchers next plan to study the longer-term effects of the device in mice.
Malliaras is establishing a new facility at Cambridge which will be able to prototype these specialised devices, which could be used for a range of conditions. Although the device was tested in an animal model of epilepsy, the same technology could potentially be used for other neurological conditions, including the treatment of brain tumours and Parkinson’s disease.
The Latest on: Epilepsy
via Google News
The Latest on: Epilepsy
- Protein anchors as a newly discovered key molecule in cancer spread and epilepsyon January 26, 2021 at 5:23 pm
Cancers and developmental disorders of the nervous system leading to behavioral disorders and epilepsy can be the result if MTOR is malfunctioning. Therefore, the cell controls MTOR activity very ...
- How medical cannabis is helping a nine-year-old boy with severe epilepsyon January 26, 2021 at 10:18 am
The mother of a nine-year-old boy with severe epilepsy, who was worried her son could die if Brexit stopped the supply of medical cannabis from the Netherlands, has been given a six-month reprieve.
- Astrocytes might be a potential new target to better treat epilepsyon January 26, 2021 at 10:06 am
A significant number of epilepsy patients does not respond to currently available drugs. A collaboration between researchers in Japan and at the Heinrich Heine University Düsseldorf now addressed a ...
- CBD for Dogs? New research backs canine hemp oil use for epilepsy and arthritison January 25, 2021 at 3:52 pm
Contact>...] COLORADO, USA - Veterinary safety ...
- BrainFocus, a computer program to locate the source of epilepsy in the brainon January 25, 2021 at 2:25 pm
About 50 million people suffer from epilepsy in the world, one-third of whom do not respond to drug treatment. In many cases it is advisable to perform a surgical intervention on the point of the ...
- Epilepsy Canada and CURE Epilepsy Announce Agreement to Team-Up to Fight for a Cureon January 25, 2021 at 11:58 am
Epilepsy research in North America has received a major boost. Epilepsy Canada, headquartered in Toronto and CURE Epilepsy, based in Chicago, ...
- Epilepsy research focused on astrocyteson January 25, 2021 at 9:56 am
During epileptic seizures, a large number of nerve cells in the brain fire excessively and in synchrony. This hyperactivity may lead to uncontrolled shaking of the body and involve periods of loss of ...
- How a young Charlotte artist copes with epilepsy, depression | Charlotte Observeron January 25, 2021 at 7:00 am
Arelys Ripoll has struggled with depression and epilepsy since childhood. Through art, she’s able to express here emotions.
- Epilepsy - Worldwide Market and Epidemiology Insights & Forecasts to 2030on January 22, 2021 at 1:08 am
Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the Epilepsy, historical ...
- Epilepsy Drug News: Why Addex Therapeutics (ADXN) Stock Is Soaring Todayon January 21, 2021 at 1:59 am
Addex Therapeutics (NASDAQ:ADXN) stock is soaring higher on Thursday after announcing news concerning a clinical trial for its epilepsy drug. Addex Therapeutics and Janssen Pharmaceuticals are working ...
via Bing News